Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Beth N McLellan

Showing results (1-10 of 77) with videos related to

Pageof 8
Sort By:
JAAD Case Reports|November 15, 2023
Incidental improvement of programmed cell death-1 receptor inhibitor-induced vitiligo after initiation of dupilumab therapy for refractory pruritusWarner Robinson, Beth N McLellan
JAAD Case Reports|July 24, 2024
Utilization of scalp cooling to prevent chemotherapy-induced alopecia in woman of skin of color with type 3 hairWarner Robinson, Beth N McLellan
JAAD Case Reports|June 9, 2020
Severe onycholysis and eyelash trichomegaly in a patient treated with erdafitinibAlana Deutsch, Beth N McLellan
JAAD Case Reports|May 9, 2020
Topical tacrolimus for refractory superficial mucoceles in a patient with chronic graft versus host diseaseAlana Deutsch, Beth N McLellan
Journal of the American Academy of Dermatology|May 22, 2019
Purified protein derivative as intralesional immunotherapy for treatment of warts: Selection of the appropriate population is crucialRoya S Nazarian, Beth N McLellan
JAMA Oncology|August 10, 2023
Addressing the Need for Diversity in Scalp Cooling TrialsWarner M Robinson, Beth N McLellan
Journal of the American Academy of Dermatology|April 26, 2020
Anticancer therapies associated with secondary cutaneous malignancies: A review of the literatureAlana Deutsch, Yevgeniy Balagula, Beth N McLellan
Dermatologic Therapy|July 7, 2021
Exacerbation of psoriasis following COVID-19 vaccination in a patient previously treated with PD-1 inhibitorKarolina Mieczkowska, Andreas Kaubisch, Beth N McLellan
JAAD International|August 19, 2021
Single-cell transcriptomics in dermatologyAlana Deutsch, Beth N McLellan, Kosaku Shinoda
Acta Oncologica (Stockholm, Sweden)|November 19, 2019
Cutaneous adult T-cell leukemia/lymphoma presenting as sweet syndromeAlana Deutsch, Mark Jacobson, Beth N McLellan
Pageof 8

Showing results (1-10 of 77) with videos related to

Sort By:
Pageof 8
JAAD Case Reports|November 15, 2023
Incidental improvement of programmed cell death-1 receptor inhibitor-induced vitiligo after initiation of dupilumab therapy for refractory pruritusWarner Robinson, Beth N McLellan
JAAD Case Reports|July 24, 2024
Utilization of scalp cooling to prevent chemotherapy-induced alopecia in woman of skin of color with type 3 hairWarner Robinson, Beth N McLellan
JAAD Case Reports|June 9, 2020
Severe onycholysis and eyelash trichomegaly in a patient treated with erdafitinibAlana Deutsch, Beth N McLellan
JAAD Case Reports|May 9, 2020
Topical tacrolimus for refractory superficial mucoceles in a patient with chronic graft versus host diseaseAlana Deutsch, Beth N McLellan
Journal of the American Academy of Dermatology|May 22, 2019
Purified protein derivative as intralesional immunotherapy for treatment of warts: Selection of the appropriate population is crucialRoya S Nazarian, Beth N McLellan
JAMA Oncology|August 10, 2023
Addressing the Need for Diversity in Scalp Cooling TrialsWarner M Robinson, Beth N McLellan
Journal of the American Academy of Dermatology|April 26, 2020
Anticancer therapies associated with secondary cutaneous malignancies: A review of the literatureAlana Deutsch, Yevgeniy Balagula, Beth N McLellan
Dermatologic Therapy|July 7, 2021
Exacerbation of psoriasis following COVID-19 vaccination in a patient previously treated with PD-1 inhibitorKarolina Mieczkowska, Andreas Kaubisch, Beth N McLellan
JAAD International|August 19, 2021
Single-cell transcriptomics in dermatologyAlana Deutsch, Beth N McLellan, Kosaku Shinoda
Acta Oncologica (Stockholm, Sweden)|November 19, 2019
Cutaneous adult T-cell leukemia/lymphoma presenting as sweet syndromeAlana Deutsch, Mark Jacobson, Beth N McLellan
Pageof 8